Active GU protocols Study number links to NCI protocol site
Prostate
R0232-Phase III Randomized Study of Interstitial Brachytherapy With or Without External Beam Radiotherapy in Patients With Intermediate-Risk Prostate Cancer
R0521-Phase III Randomized Study of Androgen Suppression (AS) and Radiotherapy (RT) Versus AS and RT Followed by Docetaxel and Prednisone in Patients With Localized, High-Risk Prostate Cancer
R0534 - Phase III Randomized Study of Prostate Bed Radiotherapy (BPRT) Alone Versus Short Term Androgen Deprivation Comprising Antiandrogen and Luteinizing Hormone-Releasing Hormone Agonist Therapy and Pelvic Lymph Node Radiotherapy With Versus Without BPRT in Patients With a Rising Prostate-Specific Antigen After Radical Prostatectomy for Prostate Cancer
S0421-Phase III Randomized Study of Docetaxel and Prednisone With Versus Without Atrasentan in Patients With Hormone-Refractory Stage IV Prostate Cancer and Bone Metastases
Renal Cell
E2804-Phase II Randomized Study of Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Patients With Metastatic Renal Cell Carcinoma
E2805-Phase III Randomized Study of Adjuvant Sunitinib Malate Versus Sorafenib in Patients With Resected Renal Cell Carcinoma
